Company Reports

Deutsche Bank: Delusional Visions of Sugar Plum Fairies


Deutsche Bank released its radical transformation plan as it seeks operational stability. Still, we and the markets are not convinced. A radical out-of-market merger with a stronger US bank makes more sense and would help systemic stability. Sell Stock and Bonds, Reduce counterparty exposures. 

Deutsche Bank: Dubious Assets & Plans as It Struggles to Survive


CEO Sewing tries to patch up the DB mottled ship with a early guidance on a "bad bank" to house illiquid Level 3s and long-dated derivatives. We take our victory lap as one of the only early warning systems on this as junior debt should take the equity contribution punishment. DB DB DB DB DB DB DB DB DB DB DB DB 

Podcast: Dangerous Derivatives Discourse


David Clarke & David Hendler discuss the realities & dangers associated with derivative instruments & technology in this 40 minute podcast. Clarke's UK police enforcement experience related to financial fraud & Hendler's Wall Street experience provide unmatched perspectives on the challenges of montioring and policing financial engineering and leading FinTech technologies. 

JPM 1Q19: Record Economic Earnings, ESG Whale Risk!


JPMorgan had knockout results and new-age economic earnings. But rising ESG Event Risk is lurking in the off-balance sheet as Viola Risk begins to review. Go to Sell on Bonds on technicals, still a Buy on Stock. Counterparty/Enterprise Risk Low, Systemic Risk Very Low. JPM JPM JPM JPM JPM JPM JPM JPM JPM JPM JPM JPM

10K Takes: Why BB&T Passed on RF & Took STI to the Merger Prom


RF's 10K highlights the difficulties of being a US regional bank in a fast-changing FinTech world. We show why BBT bear-hugged STI instead of RF as FCF rules the roost. RF RF RF RF RF RF RF RF RF RF RF STI STI STI STI STI STI STI STI STI STI BBT BBT BBT BBT BBT BBT BBT BBT BBT BBT

SocGen 4Q18: Punching Above Its Weight Class, Will It Get KOd?


SocGen disappointed more than BNP as it showed its high risk appetite to short volatility across equity, fx and credit derivatives. With a price/book close to 30%, can anyone find management creditable? Not much business diversity and stuck in slow growth France. Sell Capital Structure, Very High Counterparty & Regulatory Risk. SOCGEN SOCGEN SOCGEN SOCGEN SOCGEN SOCGEN SOCGEN SOCGEN SOCGEN SOCGEN SOCGEN SOCGEN

BNP 4Q18: Snurfing Wars in Equities Derivatives


BNP's Equity Derivatives/Structured Notes nightmares just beginning as Trumpian Tweets will rock the geopolitics and VIX volatility for the foreseeable future. Even if they close up structuring shop, where do they get those juicy earnings? Big equity problem that will continue to hit debt. Counterparty & Regulatory Risk is High and near Very High. BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP BNP

Citi: Goes Green, Bonding to Climate Change


We present our first co-authored Green Bond article on Citi's inaugural issuance last week. Looks like a Buy in Eurodollar land. We discuss the emergence of the market and Citi's participation.

MS 4Q18: Bad Case of Markets Flu, Should Recover


MS received a major torpedo revenues hit, as millennial traders learn there is risk with returns. Still all is good with the franchise and it should reboot to compete well in global financial sweepstakes. Buy on capital structure, Counterparty/Reg risk Medium. MS MS MS MS MS MS MS MS MS MS 

BAC 4Q18: BAC in the Hunt, Watch Out Jamie!


BAC showed a strong rebound in 2018 across consumer, wealth mgt, and commercial lending. Capital markets looking to rebound with more risk-on profile. We are a Buy on Capital Structure. Counterparty/Regulatory risk Low. BAC BAC BAC BAC BAC BAC BAC BAC BAC BAC

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42